Lataa...
Eradication of HCV Infection with the Direct-Acting Antiviral Therapy in Renal Allograft Recipients
Hepatitis C virus (HCV) infection unfavorably affects the survival of both renal patients undergoing hemodialysis and renal transplant recipients. In this subset of patients, the effectiveness and safety of different combinations of interferon-free direct-acting antiviral agents (DAAs) have been ana...
Tallennettuna:
| Julkaisussa: | Biomed Res Int |
|---|---|
| Päätekijät: | , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Hindawi
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6507153/ https://ncbi.nlm.nih.gov/pubmed/31179323 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/4674560 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|